Accuracy of the Apple Watch Series 4 for Detection of Heart Rhythm: A Pilot Study

Sponsor
The Cleveland Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT03798613
Collaborator
Case Western Reserve University (Other)
50
1
2
3.2
15.5

Study Details

Study Description

Brief Summary

The objective of this study is to assess the accuracy of the Apple Watch 4 Series watch in generating an ECG that is suitable for determination of heart rhythm compared to rhythms monitored via telemetry. Secondary objective is to assess the accuracy of the Apple Watch 4 series watch in identifying atrial fibrillation when it is present.

Condition or Disease Intervention/Treatment Phase
  • Device: Apple Watch 4 Series Device
  • Device: Continuous Telemetry Monitor
N/A

Detailed Description

The study will assess the accuracy of the Apple watch 4 series watch when worn by post-operative cardiac surgery patients after they have transferred from the ICU to the cardiac telemetry unit.

During testing each subject will wear:
  1. An Apple Watch 4 series watch for no more than 5 minutes.

  2. Standard continuous telemetry monitor

The location of the watch (left or right wrist) will be randomly assigned.

Heart rate and rhythm will be assessed by obtaining tracings from the Apple Watch 4 series watch while at the same point in time obtaining tracings from a standard telemetry monitor.

ECGs from the Apple Watch 4 will be collected by asking the patient to place his/ her finger on the digital crown of the Apple Watch 4 for 30 seconds. The rhythm displayed by the Apple Watch 4 will be viewed on the Apple health app (available on the iPhone 8) and will be saved for subsequent viewing and analysis.

Each enrolled patient will have a minimum of three assessments of heart rhythm per day for at least two days, generating a minimum of six data points per patient.

After conclusion of the study for each subject, the ECG's from the health app pertaining to that subject will be reviewed by a board certified cardiologist as will the telemetry tracings.

In order to obtain tracings of new onset post-operative atrial fibrillation. 50% of the subjects enrolled will be in sinus rhythm and 50% will be in atrial fibrillation at the time of enrollment.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Accuracy of the Apple Watch Series 4 for Detection of Heart Rhythm: A Pilot Study
Actual Study Start Date :
Dec 21, 2018
Actual Primary Completion Date :
Mar 29, 2019
Actual Study Completion Date :
Mar 29, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Apple Watch 4 Series Device

Apple watch 4 series heart rate monitoring device

Device: Apple Watch 4 Series Device
tracings from the apple watch 4 series watch

Active Comparator: Continuous Telemetry

Standard continuous telemetry monitoring device

Device: Continuous Telemetry Monitor
tracings from the continuous telemetry monitor

Outcome Measures

Primary Outcome Measures

  1. Heart rate accuracy compared to telemetry [5 minutes]

    Apple Watch 4 Series heart rate monitor device accuracy compared to standard continuous telemetry monitor. This will be expressed by the correlation coefficient.

Secondary Outcome Measures

  1. Heart rhythm accuracy compared to telemetry [5 minutes]

    Apple Watch 4 Series heart rhythm device accuracy compared to standard continuous telemetry monitor. This will be expressed by the correlation coefficient.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years

  • Post-operative cardiac surgery patients on the cardiac telemetry floors at the Cleveland Clinic Main Campus

Exclusion Criteria:
  • Presence of a cardiac pacemaker

  • Use of a radial artery graft for coronary artery bypass grafting

  • Tattoos located on the skin of the wrist or forearm where the Apple Watch 4 will be placed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Cleveland Ohio United States 44195

Sponsors and Collaborators

  • The Cleveland Clinic
  • Case Western Reserve University

Investigators

  • Principal Investigator: Marc Gillinov, MD, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marc Gillinov, MD, Principal Investigator, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT03798613
Other Study ID Numbers:
  • 18-1397
First Posted:
Jan 10, 2019
Last Update Posted:
Apr 9, 2019
Last Verified:
Apr 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marc Gillinov, MD, Principal Investigator, The Cleveland Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 9, 2019